3D Ultrasound Market Size, Share & Trends Analysis Report By Application (General Imaging, Cardiovascular, POC), By End Use (Handheld, Cart/Trolley), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027

Report Overview

The global 3D ultrasound market size was valued at USD 2.9 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2020 to 2027. The key drivers of the market are the increasing incidence of target disease, the rising number of diagnostic centers, and a growing preference for minimally invasive procedures. Moreover, technological advancements in 3D imaging have helped in improving diagnosis by providing immediate clinical information and also helped in reducing healthcare costs. The 3D imaging technology capabilities have spread across all clinical applications from cardiology, gynecology & obstetrics to an emergency point of care. The cost-effectiveness, speed, and efficacy nature of 3D imaging are some of the added advantages over other imaging modalities. In terms of technology, 3D ultrasound imaging is going through an evolution of miniaturization.

3D ultrasound imaging has the potential to provide real-time imaging of the anatomical structure. Real-time 3D ultrasound has more advantages for guiding interventional procedures. These devices can visualize real-time tissue organs in 3D. Moreover, 3D ultrasound has a better acquisition rate of 30 volumes per second compared with volumetric imaging alternatives including CT and MRI. Thus, it is expected to improve clinical outcomes and also reduce the patient’s hospital costs.

The rising number of product launches and FDA approval for 3D technologies are also boosting growth. For instance, in May 2020, Philips Healthcare (Amsterdam, Holland) received FDA approval to market its ultrasound solution for the management of COVID-19-related cardiac and lungs complication. Moreover, artificial intelligence-guided 3D imaging is also expected to drive the market for 3D ultrasound. For instance, in February 2020, Caption Health received the FDA approval for an ultrasound software that guides clinicians in capturing images of the heart.

End-use Insights

Cart/trolley-based devices dominated the market and accounted for a revenue share of 80.0% in 2019. The high usage of these devices and the increasing number of product launches are contributing to the growth of the market. For instance, in July 2020, Hologic, Inc. launched SuperSonic Mach 40, a cart-based ultrasound system in the U.S. Rising healthcare expenditure and the increasing number of hospital admission due to various cardiac and pulmonary diseases are also boosting the demand for the segment.

The handheld segment is expected to witness a CAGR of 8.2% during the forecast period. Improvement in ease of use has been an essential factor in the growth of POC 3D ultrasound imaging. Many companies are focusing on the development of a handheld ultrasound system that can easily be transported anywhere. For instance, in November 2015, Philip Healthcare opened a new point of care segment. The company launched Lumify, a mobile-based ultrasound system.

Application Insights

The general imaging segment dominated the market for 3D ultrasound and accounted for a revenue share of 29.4% in 2019. Rising adoption of these devices and an increasing number of product launches are driving the growth. For instance, in February 2018, GE Healthcare launched LOGIQ E10, an AI-based radiology ultrasound system designed to produce high-quality images for various body parts, including the heart, testes, thyroid, abdomen, breast, and liver. The cardiac 3D ultrasound segment also accounts for a considerable amount of market share. The evolution of transcatheter procedures such as Tricuspid Valve Repair (TTVR), Transcatheter Aortic Valve Replacement (TAVR), and transcatheter mitral valve repair (TMVR) used to repair structured cardiac disease, has led to growth in the preoperative planning market.

The point of care ultrasound segment is expected to grow at the fastest rate owing to the increasing usage of these devices in hospitals and clinics. With lower system costs and miniaturization of technology, the demand for point-of-care ultrasound is expected to increase. Major clinical application of point of care 3D ultrasound systems is cardiac/critical care, musculoskeletal, emergency medicine (urgent and hospital-based), anesthesia, and pain management. The segment has shown significant growth in musculoskeletal applications due to the ability to visualize soft tissue in joint space, ligaments, tendons, and muscles.

Regional Insights

North America accounted for the largest market share of 27.3% in 2019 and is expected to maintain its dominance over the forecast period. Regionally, the market for 3D ultrasound is segmented into North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The increasing number of product launches and favorable reimbursement are the factors contributing to North America's dominance. The region is also witnessing continuous technological advancement in the field of 3D imaging. Moreover, increasing research and development expenses and a rising patient pool are also boosting the market growth.

In Asia Pacific, the market for 3D ultrasound is likely to witness the fastest growth rate during the forecast period. A rising patient pool and a rising preference for minimally invasive surgeries are contributing to the growth. The use of ultrasound outside of traditional core applications; cardiology radiology, and women’s health remained underuse in the developing market. As a result, there is a high expectation that new users of 3D ultrasound imaging would increase the demand in the region.

Key Companies & Market Share Insights

The market for 3D ultrasound was dominated by GE Healthcare with an approximate market share of 35.0% in 2019. The major players in industries are heavily investing in research and development and are continuously innovating their present offerings. For instance, in July 2020, Hoya Corp and Hitachi, Ltd. announced a five-year contract for an endoscopic ultrasound system to strengthen their technical collaboration. The major players in the industries are focusing on the miniaturization of devices with a better visualization. Companies are also focusing on providing tools for 3D technologies, such as multiplanar display, which helps in rendering a better view. Moreover, companies are also focusing on the implementation of artificial intelligence technology in 3D ultrasound. Some of the prominent players in the 3D ultrasound market include:

• GE Healthcare

• Philips Healthcare

• Canon

• Hitachi

• Siemens

• Fujifilm

3D Ultrasound Market Report Scope

Segments Covered in the Report 

This report forecasts revenue growth at global, regional, and country levels as well as provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global 3D ultrasound market report based on application, end-use, and region.

• Application Outlook (Revenue, USD Million, 2016 - 2027)

  • General imaging

  • Cardiovascular

  • Obstetrics and gynecology

  • Point of care

• End-use Outlook (Revenue, USD Million, 2016 - 2027)

  • Handheld

  • Cart/Trolley

• Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America

    • The U.S.

    • Canada

  • Europe

    • The U.K

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE